Spanish Cell Therapy Network (TerCel): 15 years of successful collaborative translational research

Downloads

Downloads per month over past year

62000

Impacto

Downloads

Downloads per month over past year

Sánchez Guijo, Fermín and García Olmo, Damián and Prósper, Felipe and Martínez, Salvador and Zapata González, Agustín and Fernández Avilés, Francisco and Toledo Aral, Juan José and Torres, Miguel and Fariñas, Isabel and Badimón, Lina and Labandeira García, José Luis and García Sancho, Javier and Moraleda, Jose María (2019) Spanish Cell Therapy Network (TerCel): 15 years of successful collaborative translational research. Cytotherapy, 22 (1). pp. 1-5. ISSN 1477-2566

[thumbnail of Zapata-DBC-Spanish-Cell-Therapy.pdf]
Preview
PDF
Creative Commons Attribution Non-commercial No Derivatives.

444kB

Official URL: https://www.sciencedirect.com/science/article/pii/S1465324919308898



Abstract

In the current article we summarize the 15-year experience of the Spanish Cell Therapy Network (TerCel), a successful collaborative public initiative funded by the Spanish government for the support of nationwide translational research in this important area. Thirty-two research groups organized in three programs devoted to cardiovascular, neurodegenerative and immune-inflammatory diseases, respectively, currently form the network. Each program has three working packages focused on basic science, pre-clinical studies and clinical application. TerCel has contributed during this period to boost the translational research in cell therapy in Spain, setting up a network of Good Manufacturing Practice–certified cell manufacturing facilities– and increasing the number of translational research projects, publications, patents and clinical trials of the participating groups, especially those in collaboration. TerCel pays particular attention to the public-private collaboration, which, for instance, has led to the development of the first allogeneic cell therapy product approved by the European Medicines Agency, Darvadstrocel. The current collaborative work is focused on the development of multicenter phase 2 and 3 trials that could translate these therapies to clinical practice for the benefit of patients.


Item Type:Article
Uncontrolled Keywords:cell therapy; regenerative medicine; research network; stem cells; translational medicine
Subjects:Medical sciences > Biology > Cytology
ID Code:62000
Deposited On:07 Sep 2020 15:21
Last Modified:09 Sep 2020 08:01

Origin of downloads

Repository Staff Only: item control page